Concepedia

Sam Wilding

SW

16

Publications

590

Citations

12

H-Index

2016

Active since

Affiliations

University of Southampton(Current)

University Hospital Southampton NHS Foundation Trust

NIHR Southampton Biomedical Research Centre

University of Glasgow

Beatson West of Scotland Cancer Centre

Sam Wilding is an author at University of Southampton specializing in cancer therapeutics, radiation oncology, and immigrant health.

ORCID

Top concepts

Publications per year

2016–2024

16

Publications

16

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial

Nick Curzen, Zoe Nicholas, Beth Stuart et al. · European Heart Journal · 2021 · 143 citations · Full text

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

Simon J. Crabb, Gareth Griffiths, Ellice Marwood et al. · Journal of Clinical Oncology · 2020 · 77 citations · Full text

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

Andrew Davies, Sharon Barrans, Louise Stanton et al. · Journal of Clinical Oncology · 2023 · 68 citations · Full text

Are environmental area characteristics at birth associated with overweight and obesity in school-aged children? Findings from the SLOPE (Studying Lifecourse Obesity PrEdictors) population-based cohort in the south of England

Sam Wilding, Nida Ziauddeen, Dianna Smith et al. · BMC Medicine · 2020 · 50 citations · Full text

Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial

Simon J. Crabb, Gareth Griffiths, Denise Dunkley et al. · European Urology · 2022 · 43 citations · Full text

, , +15

Rows per page

1–5 of 16